A Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Study to Assess the Safety and Efficacy of Doripenem Compared With Imipenem in the Treatment of Subjects With Ventilator-Associated Pneumonia.
Latest Information Update: 06 Oct 2021
At a glance
- Drugs Doripenem (Primary) ; Imipenem/cilastatin
- Indications Bacterial infections; Ventilator associated pneumonia
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development; Janssen-Cilag
- 05 Oct 2021 This trial has been completed in France (Global end date: 15 June 2011).
- 17 Jul 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 17 Jul 2012 Actual number of patients changed from 273 to 274, as reported by ClinicalTrials.gov.